Compiled by Giuseppe Curigliano, Division of Medical Oncology, European Institute of Oncology, Milan, Italy

Read the ecancer blog to discover more about these recent news stories, compiled by an expert at the IEO.


Expression of androgen receptors in primary breast cancer


Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer


Potential Clinical Significance of a Plasma-Based KRAS Mutation Analysis in Patients with Advanced Non�Small Cell Lung Cancer

Plasma KRAS mutation status is associated with a poor tumour response to EGFR-TKIs in NSCLC.

Phase I oncology studies: Evidence that in the era of targeted therapies patients on lower doses do not fare worse